USA - NYSE:AMWL - US03044L2043 - Common Stock
The current stock price of AMWL is 4.05 USD. In the past month the price decreased by -25.69%. In the past year, price decreased by -51.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.38 | 48.08B | ||
| DOCS | DOXIMITY INC-CLASS A | 30.26 | 9.29B | ||
| WAY | WAYSTAR HOLDING CORP | 26.36 | 6.74B | ||
| HTFL | HEARTFLOW INC | N/A | 2.33B | ||
| CERT | CERTARA INC | 16.66 | 1.34B | ||
| PHR | PHREESIA INC | N/A | 1.30B | ||
| SDGR | SCHRODINGER INC | N/A | 1.30B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.22B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 8.49 | 1.03B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 624 | 1.06B | ||
| HSTM | HEALTHSTREAM INC | 35.99 | 725.29M |
American Well Corp. engages in the provision of online healthcare services. The company is headquartered in Boston, Massachusetts and currently employs 877 full-time employees. The company went IPO on 2020-09-17. The company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.
AMERICAN WELL CORP-CLASS A
75 State Street, 26th Floor
Boston MASSACHUSETTS 02109 US
CEO: Roy Schoenberg
Employees: 877
Phone: 16172053500
American Well Corp. engages in the provision of online healthcare services. The company is headquartered in Boston, Massachusetts and currently employs 877 full-time employees. The company went IPO on 2020-09-17. The company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.
The current stock price of AMWL is 4.05 USD. The price increased by 1.5% in the last trading session.
AMWL does not pay a dividend.
AMWL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
AMERICAN WELL CORP-CLASS A (AMWL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-7.89).
The Revenue of AMERICAN WELL CORP-CLASS A (AMWL) is expected to decline by -0.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
AMERICAN WELL CORP-CLASS A (AMWL) has a market capitalization of 65.41M USD. This makes AMWL a Micro Cap stock.
ChartMill assigns a fundamental rating of 3 / 10 to AMWL. While AMWL has a great health rating, there are worries on its profitability.
Over the last trailing twelve months AMWL reported a non-GAAP Earnings per Share(EPS) of -7.89. The EPS increased by 46.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.56% | ||
| ROE | -44.5% | ||
| Debt/Equity | 0 |
15 analysts have analysed AMWL and the average price target is 10.05 USD. This implies a price increase of 148.24% is expected in the next year compared to the current price of 4.05.
For the next year, analysts expect an EPS growth of 55.23% and a revenue growth -0.84% for AMWL